10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2016 | |||
Consolidated Statement of Earnings | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 17, 2017) | |||
(In Millions) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
Net Sales | $ 20,853 | 20,405 | 20,247 |
Cost of products sold, excluding amortization of intangible assets | 9,024 | 8,747 | 9,218 |
Amortization of intangible assets | 550 | 601 | 555 |
Research and development | 1,422 | 1,405 | 1,345 |
Selling, general and administrative | 6,672 | 6,785 | 6,530 |
Total Operating Cost and Expenses | 17,668 | 17,538 | 17,648 |
Operating Earnings | 3,185 | 2,867 | 2,599 |
Interest expense | 431 | 163 | 150 |
Interest income | (99) | (105) | (77) |
Net loss on extinguishment of debt | 18 | ||
Net foreign exchange (gain) loss | 495 | (93) | (24) |
Other (income) expense, net | 945 | (281) | 14 |
Earnings from Continuing Operations Before Taxes | 1,413 | 3,183 | 2,518 |
Taxes on Earnings from Continuing Operations | 350 | 577 | 797 |
Earnings from Continuing Operations | 1,063 | 2,606 | 1,721 |
Earnings from Discontinued Operations, net of taxes | 321 | 65 | 563 |
Gain on sale of Discontinued Operations, net of taxes | 16 | 1,752 | |
Net Earnings from Discontinued Operations, net of taxes | 337 | 1,817 | 563 |
Net Earnings | 1,400 | 4,423 | 2,284 |
Basic Earnings Per Common Share -- | |||
Continuing Operations (in dollars per share) | 0.71 | 1.73 | 1.13 |
Discontinued Operations (in dollars per share) | 0.23 | 1.21 | 0.37 |
Net Earnings (in dollars per share) | 0.94 | 2.94 | 1.50 |
Diluted Earnings Per Common Share -- | |||
Continuing Operations (in dollars per share) | 0.71 | 1.72 | 1.12 |
Discontinued Operations (in dollars per share) | 0.23 | 1.20 | 0.37 |
Net Earnings (in dollars per share) | 0.94 | 2.92 | 1.49 |
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) | 1,477 | 1,496 | 1,516 |
Dilutive Common Stock Options (in shares) | 6 | 10 | 11 |
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) | 1,483 | 1,506 | 1,527 |
Outstanding Common Stock Options Having No Dilutive Effect (in shares) | 5 | 1 | 1 |
External Links | |
ABBOTT LABORATORIES (ABT) Fiscal Year 2016 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |